The presently pending petition for en banc review in Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC has been addressed by Sherry Knowles and Meredith Addy and is supported by a number of amicus briefs. The patent in issue has been described by the present author as a paradigm of patent eligibility, supporting the argument that en banc review is merited. Mayo has now filed its response brief, submitted on May 7, and argues that the panel’s decision invalidating the asserted claims as ineligible properly applied the two-step Alice framework in light of precedent, that the full Court need not re-examine it, and accordingly, that Appellants’ petition should be denied.
Recent Posts
- CAFC Affirms Obviousness of Vehicle ID Claims, Finds Substitute Claims Ineligible Under Section 101
- U.S. Patent Litigation Trends in 2025: Patterns Behind the Numbers
- Other Barks & Bites for Friday, September 26: Trump Announces 100% Tariff on Patented Pharmaceuticals; Judge Alsup Approves $1.5 Billion Anthropic AI Settlement; and DOJ Weaponization Group Reportedly Investigating Secret Patent Reviews
- CAFC Vacates TTAB Decision Over Inconsistent Application of DuPont Factors
- Squires Signs First Patents, Signals Commitment to Keep Emerging Technologies Eligible